Predictimmune and the Crohns & Colitis Foundation Announce a Joint Study to Validate and Prove Efficacy of First Prognostic Test for IBD in the US Market

The jointlysponsored study is expected to advance progress towards personalised medicine for IBD patients in the US PredictImmune developers of pioneering prognostic tools for guiding treatment options and improving patient outco...